Early signs of nerves hurt Genedrive shares

by Alistair Strang from Trends and Targets |

Share on:

The share price has tumbled since May's peak, so our chartist studies the probability of another rally.

Genedrive (LSE:GDR) 

As we meander toward the next phase of Covid-19, an unpleasant number of shares which experienced 'enhanced expectation' growth are seeing their share price look more vulnerable.

Unfortunately, Genedrive (LSE:GDR) are on the edge of joining this particular club. 
 
It's important to stress we're only seeing early signs of nerves against this share price. It needs to weaken below 90p to provoke serious concern as this is liable to promote reversal to an initial 82p.

Should such reversal occur, it will be worth paying attention to any initial drop movement due to the severe risks if 82p breaks on an initial drop.

We would expect some sort of rebound anyway, if 82p makes itself known but the danger is fairly simple. A break below 82p risks further reversal down to 51p or worse.

It's quite odd, for companies whose share prices have ridden the Covid-19 wave, bad news for their price is liable to be regarded as good news for everyone else.

Whether the virus fades away or, ideally, a cure is found, the multitude of companies offering testing will doubtlessly suffer. This level of suffering is liable to be almost a mirror image of any 'enhanced expectation' price movement.

In the case of Genedrive, we can currently calculate an ultimate bottom of 12p. This is the point below which all numbers are prefaced with minus signs.
 
As always, there's a bit of a "however" and for Genedrive, above 134p should prove capable of trigging movement to an initial 150p with secondary, if exceeded, at 171p.

The visuals certainly suggest, if 171p makes itself known, we should expect some hesitation thanks to what looks like a glass ceiling.

This particular share now needs to trade above 261p to suggest the price is entering a brave new world, upwards, for the longer-term.

Source: Trends and Targets      Past performance is not a guide to future performance

Alistair Strang has led high-profile and "top secret" software projects since the late 1970s and won the original John Logie Baird Award for inventors and innovators. After the financial crash, he wanted to know "how it worked" with a view to mimicking existing trading formulas and predicting what was coming next. His results speak for themselves as he continually refines the methodology.

Alistair Strang is a freelance contributor and not a direct employee of Interactive Investor. All correspondence is with Alistair Strang, who for these purposes is deemed a third-party supplier. Buying, selling and investing in shares is not without risk. Market and company movement will affect your performance and you may get back less than you invest. Neither Alistair Strang, or interactive investor will be responsible for any losses that may be incurred as a result of following a trading idea. 

These articles are provided for information purposes only. Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties. The content is not intended to be a personal recommendation, and is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.

Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.

get more news and expert articles direct to your inbox
Sign up for a free research account and get the latest news and discussion, and create your own Virtual Portfolio
sponsored articles from our partners